Saez-Llorens X, Norero X, Mussi-Pinhata MM, Luciani K, et al. Safety and immunogenicity of a ChAd155-vectored respiratory syncytial virus vaccine in infants 6-7 months of age: a phase 1/2 randomized trial. J Infect Dis 2023 Jul 21:jiad271. doi: 10.1093.
PMID: 37477875